sharpstechnology.com - צמיחת מכירות משנה לשנה (TTM) STSS

The 12-month year-over-year revenue trend demonstrates the expansion of Sharps Technology, Inc. (STSS) through B2B sales of innovative syringes, with the latest figure standing at 0.00. Growth is complicated by pricing pressure from global suppliers and the consolidation of government procurement. However, the implementation of automated production lines for smart instruments creates positive momentum, despite a temporary shortage of working capital.

The scaling of production for safe blood collection systems at Sharps Technology, Inc. (STSS) directly determines revenue dynamics, as reflected by the rolling year-over-year revenue growth trend. This indicator measures the percentage change in revenue over 12 months relative to the previous period, smoothing out short-term fluctuations and allowing investors to assess the real speed of business expansion against distribution risks.